Navigation

Tag, you're it! PSN's website uses tags to categorize content. You are viewing a list of content tagged as Prescription Drugs Reforms.

Prescription Drugs Reforms

Preventing Loss of Medicaid Drug Rebate Funds for States

Enzo Pastore on July 1, 2010 - 11:31am
While the new Affordable Health Care law provides a variety of funding opportunities for states, one provision in the health law that could shift billions of dollars from cash-strapped states to the federal government.  Under the National Medicaid Drug Rebate Program created by the Omnibus Budget Reconciliation Act of 1990, drug manufacturers are required to enter into agreements that provide rebates for Medicaid purchased drugs, establishing a 15% minimum level of rebates.  Up until now, the rebates were divided between the states and the federal government.  But under the new health reform law, a significant portion of the rebates will go solely to Washington beginning this year.

Prescription Drugs Reform: Multi-State Agenda Campaign Update

PSN on March 25, 2010 - 5:35pm
Both to address the burden of prescription drug costs for consumers and ease their own state budgets, states across the country are moving reforms to lower the cost and increase the quality of prescription drug decisions made by providers.

While DC Delays, States Move Forward on Health Care Reforms

Enzo Pastore on January 28, 2010 - 2:18pm
As Congress delays moving forward on the passage of comprehensive health care reform, progressive state leaders from across the country have been demanding passage of reform as critical for families across the nation.  But that doesn't mean they are waiting; state leaders are moving forward, laying the groundwork for how national changes should be implemented, and creating the momentum for other meaningful health care reforms in their states.

“Gift Ban and Disclosure” — Reduce Costs, Ensure Safety and Accuracy in Prescribing Decisions: Key Facts, Polling, Best Practic

Adam Thompson on December 2, 2009 - 5:43pm
Policy Overview:  Require the industry to disclose information about advertising and marketing spending, and prohibit gifts and payments to health care practitioners from pharmaceutical and medical device manufacturers.

"PBMs” — Protect Against Unfair Drug Industry Practices: Key Facts, Polling, Best Practices

Adam Thompson on December 2, 2009 - 5:40pm
Policy Overview:  Regulate Pharmacy Benefits Managers (PBMs), who act as middlemen between drug manufacturers and public and private health plans, negotiating prices for prescription drugs. The PBM industry is highly corruptible and lax oversight of PBM practices has resulted in ethical lapses and instances of PBMs pocketing discounts they negotiated for health plans, rather than forwarding discounts through to clients.  Require transparency, a fiduciary relationship, and annual audits of all PBMs to ensure that the full value of negotiated discounts, rebates, or other financial considerations are passed through. 

Conference Call: Prescription Drug Reforms

When: 
12/01/2009 - 4:00pm

 

PSN hosted a conference call on December 1st at 4pm EST with national experts and legislative leaders to discuss Prescription Drug Reforms and the 2010 Multi-State Agenda. Speakers discussed policy details, how federal reform could impact these initiatives, and best practices for building campaigns and moving Rx reform initiatives.

Rx Reforms to Address Budget Deficits and Ensure Quality of Medications

Adam Thompson on November 23, 2009 - 2:06pm
As part of our Shared Multi-State Agenda, the Progressive States Network is working with legislators, advocates and leading experts to promote Rx reforms in 2010 that will reduce health care costs for consumers, businesses, and state and local governments, and will help ensure access to safe and effective medications.  Through coordinated, strategic support, PSN and our allies will be working to introduce and advance Rx reforms that will help address state budget deficits and improve access to quality medications in as many states possible; providing model legislation, policy analysis, messaging and more - all of which has been gathered and will be constantly updated on our Prescription Drug Reform Shared Agenda web page.